"Recreational cannabis dispensary openings are associated with a significant decrease in opioid fills among commercially insured adults in the US," the study's authors concluded.
"Almost one-third of patients experiencing moderate to severe pain at enrollment saw a meaningful reduction in pain symptoms within four months of treatment," researchers determined.